 A bombshell report commissioned by the National Cancer Institute claims that the country's four-decade 'War on Cancer' has largely been waged against 'a vastly misunderstood 'enemy,' that in many cases represented no threat to human health whatsoever.' As reported by the Sleuth Journal , which has been covering the cancer issue, particularly 'the dark side of breast cancer awareness month,' what is needed to correct this injustice is a 'complete reclassification of some types of 'breast cancer' as benign lesions,' such as 'ductal carcinoma in situ (DCIS).' In addition, the Journal says it has repeatedly pointed out that breast screenings are not only themselves highly carcinogenic, but have also led to an 'epidemic of 'overdiagnosis' and 'overtreatment' in U.S. women,' amounting to about 1.3 million cases over the past three decades. [Reporter's note: selfnews editor Mike Adams, the Health Ranger , really brought that latter point home when he took Angelina Jolie to task in 2013 over her allegedly preventive double mastectomy .] In recent days, a panel commissioned by the National Cancer Institute published its report in the Journal of the American Medical Association (JAMA) confirming that everyone should stop calling low-risk lesions like DCIS and high-grade prostatic intraepithelial neoplasia (HGPIN) 'cancer.' Reclassifying low-risk lesions has wide-reaching implications The following are the far and wide-reaching implications to this recommendation, as reported by the Sleuth Journal : 